Digital health partner channels depend on BAAs, legal review cycles, and co-marketing agreements that most marketing teams have never handled. We build the partner marketing infrastructure – tiering, enablement, compliance-cleared assets, attribution – so your EHR marketplace listing, health system co-marketing deals, and employer benefits channel generate trackable pipeline instead of remaining a logo on a slide.
The Challenge
Your EHR marketplace listing and health system co-marketing agreements generate no traceable pipeline
You got the App Orchard or Oracle Health marketplace listing live, signed a co-marketing clause with a health system, and then nothing happened – no lead source, no attribution, no way to tell the board which partner motion is worth doubling down on. Meanwhile you're paying account management time to maintain the relationship with no evidence it's converting. In a category where CAC is already brutal, an unmeasured partner channel is a cost center pretending to be a growth channel.
Every co-branded asset gets stuck in legal because no one established the compliance path first
A health system partner asks for a joint case study or co-branded one-pager, and the request sits for six weeks bouncing between your legal team and theirs because there's no BAA-aware template, no pre-cleared claims language, and no standing process for who signs off on what. By the time the asset ships, the partner's marketing calendar has moved on and the goodwill is spent. This isn't a legal problem – it's a marketing operations problem that legal is compensating for.
Direct sales and channel partners are competing over the same health system accounts
Your enterprise reps and your distribution partners are both working the same IDN without knowing it, quoting different pricing, and confusing the same VP of clinical operations. There's no rules-of-engagement document, no account registration process, and no shared visibility into who's touching what. Partners notice when they get burned once and quietly deprioritize you in favor of a competitor who respects the lane.
Partner enablement materials are generic sales collateral with the logo changed
Your partners' sales reps are handing a one-pager to a CMIO, a security review team, and a procurement lead who each need a completely different argument – clinical validation for one, integration architecture for another, total cost of ownership for the third. If your enablement kit is one generic deck, the partner's rep either improvises badly or doesn't pitch you at all, and you never find out which.
How We Can Help
We begin by auditing what actually exists: every BAA, MSA, and co-marketing clause you've signed, every partner relationship your CEO or BD lead can identify, and every piece of collateral currently circulating. Most digital health companies are surprised by what emerges – dormant agreements with genuine co-marketing rights no one is using, alongside active partnerships with no supporting materials whatsoever.
Next, we create a partner tiering model based on revenue potential and required effort, rather than relationship warmth alone. EHR marketplace listings, health system co-marketing agreements, and employer benefits broker relationships each require a distinct playbook because the buyer, compliance path, and sales motion differ. A benefits broker focuses on renewal season and employer ROI messaging. A health system co-marketing partner prioritizes clinical credibility and system-level risk. Treating them alike is why most partner programs lose momentum.
Compliance is integrated into the workflow rather than added afterward. We collaborate with your legal team once to define pre-cleared claims language and a BAA-aware asset template, so future co-branded case studies, one-pagers, and webinar invitations don't restart the legal review clock each time. This step alone typically reduces asset turnaround from weeks to days.
Enablement kits are created by stakeholder, not by partner. The same core proof points are presented in three formats: a clinical validation summary for the CMIO or clinical champion, an integration and security brief for IT, and a total-cost-of-ownership case for procurement. Your partner's rep receives exactly what they need for the room they're entering, which separates a partner who actively sells you from one who allows your listing to gather dust.
We also establish rules of engagement between your direct sales team and channel partners – account registration, deal conflict resolution, and shared visibility into which accounts are being worked and by whom. This is often the quickest win in the entire engagement because it stops the active bleeding before another deal becomes confused.
What sets this apart from a traditional channel agency retainer is that we embed. You get an operator who joins your partner reviews, observes the real friction points, and adapts the playbook based on what's truly happening in the field – not a quarterly deck of recommendations no one implements. As outlined in our broader approach to <a href="/services/strategy/">growth strategy</a>, we create systems your team can operate without us, rather than a dependency.
What we deliver
- Partner segmentation and tiering model – EHR marketplace, health system co-marketing, and benefits broker channels each get their own playbook
- Compliance-cleared co-marketing asset library, built once with legal so future assets don't restart the review cycle
- Stakeholder-specific enablement kits (clinical, IT/security, procurement) built from shared proof points
- Partner attribution and reporting dashboard tied to your CRM, so partner-sourced pipeline is visible, not assumed
A partner channel that can't answer 'which deals came from which partner' isn't really a channel – it's a collection of relationships you're hoping will pay off.
Our Methodology
The first 30 days focus on an audit, not a strategy session. We gather every BAA, MSA, and co-marketing agreement you've signed, interview your BD and partner leads, and map the true status of every partner relationship against the rights documented on paper. Most companies uncover gaps in both directions – rights they aren't exercising and obligations they aren't fulfilling.
Days 31 through 60 focus on building: the tiering model, compliance-cleared templates developed with your legal team, stakeholder-specific enablement kits, and rules of engagement between direct and channel sales. This is where most traditional agencies would deliver a binder. We create the actual assets and workflows your team will put into practice.
The last 30 days are a live pilot involving two or three partners – rather than all of them simultaneously. We test the new playbook, assets, and attribution tracking through real co-marketing motions, measure what changed, and refine the model before rolling it out across the entire partner roster. You finish the sprint with a working system, not merely a recommendation.
Our Working Process
Week one centers on discovery: auditing partner agreements, interviewing stakeholders across BD, sales, and legal, and reviewing every current co-marketing asset. By the end of week two, you'll receive a gap map showing where rights, materials, and compliance processes are misaligned.
By day 30, you'll have the tiering model and a prioritized list of partners that should receive enablement kits first, based on pipeline potential. By day 60, compliance-cleared templates and stakeholder-specific materials are complete and being used in at least one live co-marketing motion. By day 90, you'll have attribution data from pilot partners showing what is actually effective.
We hold weekly working sessions with the person who owns partner relationships on your team – typically a BD lead or head of marketing – along with ad hoc availability for time-sensitive needs, such as a health system partner requesting an asset on a two-week deadline. This isn't a monthly check-in retainer; it's an operator embedded within your partner motion.
What we need from you: access to current partner agreements and contacts, a designated point person who can schedule legal review, and candor about which partnerships are genuinely active versus aspirational. The audit only succeeds when we're examining the true state of affairs.
- Traceable partner-sourced pipeline instead of unmeasured relationship maintenance
- Faster co-marketing asset turnaround through pre-cleared compliance templates
- Reduced channel conflict between direct sales and partner-sourced deals
- Partner enablement material that partner reps actually use because it matches their buyer
If your digital health company needs partner & channel marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does partner and channel marketing cost for a digital health company?
It depends on the number of partner tiers you're activating and the amount of compliance work needed up front – a company with three inactive EHR marketplace listings and no BAA-aware templates requires more foundational work than one with an active health system co-marketing motion that simply needs stronger enablement. We scope engagements based on week-one audit findings instead of quoting a flat retainer before reviewing your actual partner agreements.
How soon will a health system co-marketing partnership begin generating pipeline?
The infrastructure – tiering, compliance templates, enablement kits – is completed within the first 60 days. Whether it generates pipeline within 90 days depends on your partner's own sales cycle and how active the relationship already is; a dormant partnership requires re-engagement time that a live relationship does not.
Do you collaborate with our current legal and compliance team or replace their process?
We collaborate with your legal team rather than bypassing them. Compliance-cleared asset templates are developed directly with whoever manages your BAAs and claims review, ensuring they reflect what your legal team will genuinely approve, not what we believe ought to be approvable.
What makes this different from working with a traditional channel marketing agency?
Most channel agencies create generic partner programs and give you a playbook to execute on your own, overlooking that digital health co-marketing involves BAA awareness and claims review that generic SaaS partner programs do not. We embed as an operator within your partner reviews and legal review cycles, creating the actual compliance-cleared assets instead of a strategy document explaining which assets should exist.
How do you evaluate ROI from partner and channel marketing?
We use a partner attribution dashboard connected to your CRM to track which deals originated from each partner tier, along with asset-level monitoring of turnaround times for co-marketing materials. We also measure leading indicators such as partner rep engagement with enablement kits, because a kit no one uses won't generate pipeline regardless of how polished it looks.
What type of digital health company is the best fit for this?
Series A through Growth-stage companies selling to health systems, payers, or employers, with at least one genuine partner relationship or marketplace listing already established – an EHR marketplace listing, a health system pilot that includes co-marketing rights, or an active benefits broker relationship. If you don't yet have any partner relationships, you probably need <a href="/services/go-to-market-for-digital-health/">go-to-market strategy</a> work first to determine who your ecosystem partners should be.
